Dr. Roy E. Strowd
Claim this profileWake Forest University Comprehensive Cancer Center
Studies Glioblastoma
Studies Brain Tumor
15 reported clinical trials
27 drugs studied
Area of expertise
1Glioblastoma
IDH negative
MET positive
MGMT positive
2Brain Tumor
Stage IV
Affiliated Hospitals
Clinical Trials Roy E. Strowd is currently running
Inebilizumab
for NMDAR Encephalitis
This trial is testing a new drug called inebilizumab for patients with severe anti-NMDAR encephalitis, a serious brain disease. The drug aims to reduce specific immune cells that cause the disease. Researchers hope this will improve symptoms and outcomes for these patients.
Recruiting0 awards Phase 2
Selinexor + Temozolomide
for Recurrent Glioblastoma
This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.
Recruiting1 award Phase 1 & 2
More about Roy E. Strowd
Clinical Trial Related2 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Roy E. Strowd has experience with
- Temozolomide
- Oxaliplatin
- Ultrasound - Serial And Tibial Nerve
- High-dose Methotrexate
- Radiation Therapy
- BAL101553
Breakdown of trials Roy E. Strowd has run
Glioblastoma
Brain Tumor
Benign Glioma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roy E. Strowd specialize in?
Roy E. Strowd focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is Roy E. Strowd currently recruiting for clinical trials?
Yes, Roy E. Strowd is currently recruiting for 5 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Roy E. Strowd has studied deeply?
Yes, Roy E. Strowd has studied treatments such as Temozolomide, Oxaliplatin, Ultrasound - Serial and Tibial Nerve.
What is the best way to schedule an appointment with Roy E. Strowd?
Apply for one of the trials that Roy E. Strowd is conducting.
What is the office address of Roy E. Strowd?
The office of Roy E. Strowd is located at: Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.